Add BrightSurf on Google Email

Norwegian Cancer Society


Breakthrough in hormonal breast cancer therapy

Anastrozole, an aromatase inhibitor, has been shown to be more effective than tamoxifen in reducing the risk of breast cancer recurrence, hot flushes, and thromboembolic events. The treatment also reduces the incidence of endometrial abnormalities and vaginal bleeding, providing a significant benefit for postmenopausal women with early...

Gene profiles predict survival

A study identified three gene expression patterns correlated with survival after chemotherapy, which outperformed the International Prognostic Index. The patterns revealed aspects of tumor biology affecting treatment response, including immune system involvement and tumor cell division.

Seven of ten cured of rectal cancer

The Norwegian Cancer Society's project has made significant strides in improving rectal cancer treatment, resulting in a 30% increase in five-year post-operative survival rates since 1999. The project aims to raise quality at hospitals whose results are still not good enough by improving surgery techniques and patient examination prior...

New treatment for skeletal metastases

A new radium isotope, radium223, has shown promise in treating skeletal metastases with less damage to bone marrow compared to traditional treatments. The isotope is incorporated into skeletal tissue via osteoclasts and emits radiation that kills cancer cells, providing pain relief and potentially improving quality of life.

More than 10 million developed cancer in 2000

In developed countries, cancer mortality is more than twice as high as in developing countries due to factors like tobacco consumption and Western nutrition. In contrast, up to 25% of malignancies in developing countries are caused by infectious agents, whereas chronic infections account for only 8% in developed nations.